Adams’ Suit Could Delay ANDA For URL/Mutual’s Mucinex Generic
This article was originally published in The Tan Sheet
Executive Summary
A lawsuit filed by Adams Respiratory Therapeutics could bring a stay of up to 30 months on FDA's approval of Mutual Pharmaceuticals and United Research Laboratories' application for a generic version of Adams' Mucinex extended-release expectorant product